Skip to main content
PMC home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(5):326–335. doi: 10.1155/S1064744997000574

Metronidazole Appears Not to Be a Human Teratogen: Review of Literature

Barbara J Struthers 1
PMCID: PMC2364581  PMID: 18476180

Abstract

Metronidazole is used to treat trichomoniasis, bacterial vaginosis, and other diseases. As is the case with many drugs, physicians often hesitate to use it during pregnancy, particularly in the first trimester. A review of the nearly four decades' worth of published literature on metronidazole use in pregnant women indicates that it is not teratogenic, regardless of the trimester in which it is used. On the other hand, a number of published studies indicate that bacterial vaginosis and trichomoniasis are associated with preterm birth and low birth weight. Treatment of these conditions with metronidazole during pregnancy may decrease the incidence of preterm birth and low birth weight, thus potentially decreasing the complications that can result from prematurity.

Full Text

The Full Text of this article is available as a PDF (823.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDREWS M. C., ANDREWS W. C. SYSTEMIC TREATMENT OF TRICHOMONAS VAGINITIS. South Med J. 1963 Nov;56:1214–1218. doi: 10.1097/00007611-196311000-00004. [DOI] [PubMed] [Google Scholar]
  2. Berget A., Weber T. Metronidazol og graviditet. Ugeskr Laeger. 1972 Oct 2;134(40):2085–2089. [PubMed] [Google Scholar]
  3. Burtin P., Taddio A., Ariburnu O., Einarson T. R., Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):525–529. doi: 10.1016/0002-9378(95)90567-7. [DOI] [PubMed] [Google Scholar]
  4. CSONKA G. W. LONG-TERM ASPECT OF TREATMENT WITH METRONIDAZOLE (FLAGYL) IN TRICHOMONAL VAGINITIS. Br J Vener Dis. 1963 Dec;39:258–260. doi: 10.1136/sti.39.4.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cantú J. M., García-Cruz D. Midline facial defect as a teratogenic effect of metronidazole. Birth Defects Orig Artic Ser. 1982;18(3 Pt A):85–88. [PubMed] [Google Scholar]
  6. Carvajal A., Sánchez A., Hurtarte G. Metronidazole during pregnancy. Int J Gynaecol Obstet. 1995 Mar;48(3):323–324. doi: 10.1016/0020-7292(94)02313-n. [DOI] [PubMed] [Google Scholar]
  7. Chacko M., Bhide S. V. Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice. J Cancer Res Clin Oncol. 1986;112(2):135–140. doi: 10.1007/BF00404396. [DOI] [PubMed] [Google Scholar]
  8. Cotch M. F., Pastorek J. G., 2nd, Nugent R. P., Hillier S. L., Gibbs R. S., Martin D. H., Eschenbach D. A., Edelman R., Carey J. C., Regan J. A. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997 Jul;24(6):353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
  9. DOYLE J. C., ROLF B. B. TREATMENT OF TRICHOMONIASIS WITH METRONIDAZOLE. A STUDY OF 99 FEMALE PATIENTS. Obstet Gynecol. 1964 Jul;24:130–134. [PubMed] [Google Scholar]
  10. DOYLE J. C., ROLF B. B. TREATMENT OF TRICHOMONIASIS WITH METRONIDAZOLE. A STUDY OF 99 FEMALE PATIENTS. Obstet Gynecol. 1964 Jul;24:130–134. [PubMed] [Google Scholar]
  11. GARDNER H. L., DUKES C. D. CLINICAL AND LABORATORY EFFECTS OF METRONIDAZOLE. Am J Obstet Gynecol. 1964 Aug 15;89:990–995. doi: 10.1016/0002-9378(64)90288-1. [DOI] [PubMed] [Google Scholar]
  12. GRAY M. S. Trichomonas vaginalis in pregnancy: the results of metronidazole therapy on the mother and child. J Obstet Gynaecol Br Emp. 1961 Oct;68:723–729. doi: 10.1111/j.1471-0528.1961.tb02801.x. [DOI] [PubMed] [Google Scholar]
  13. Giknis M. L., Damjanov I. The transplacental effects of ethanol and metronidazole in Swiss Webster mice. Toxicol Lett. 1983 Oct-Nov;19(1-2):37–42. doi: 10.1016/0378-4274(83)90259-x. [DOI] [PubMed] [Google Scholar]
  14. Glowinski M., Chrusciel A. La trichomonase de la femme enceinte et son traitement par le 8823 RP. Gynecol Prat. 1964;15(4):239–246. [PubMed] [Google Scholar]
  15. Gravett M. G., Hummel D., Eschenbach D. A., Holmes K. K. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol. 1986 Feb;67(2):229–237. doi: 10.1097/00006250-198602000-00013. [DOI] [PubMed] [Google Scholar]
  16. Gravett M. G., Nelson H. P., DeRouen T., Critchlow C., Eschenbach D. A., Holmes K. K. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 1986 Oct 10;256(14):1899–1903. [PubMed] [Google Scholar]
  17. Hardy P. H., Hardy J. B., Nell E. E., Graham D. A., Spence M. R., Rosenbaum R. C. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet. 1984 Aug 11;2(8398):333–337. doi: 10.1016/s0140-6736(84)92698-9. [DOI] [PubMed] [Google Scholar]
  18. Hauth J. C., Goldenberg R. L., Andrews W. W., DuBard M. B., Copper R. L. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 1995 Dec 28;333(26):1732–1736. doi: 10.1056/NEJM199512283332603. [DOI] [PubMed] [Google Scholar]
  19. Heisterberg L. Placental transfer of metronidazole in the first trimester of pregnancy. J Perinat Med. 1984;12(1):43–45. doi: 10.1515/jpme.1984.12.1.43. [DOI] [PubMed] [Google Scholar]
  20. Hillier S. L., Martius J., Krohn M., Kiviat N., Holmes K. K., Eschenbach D. A. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 1988 Oct 13;319(15):972–978. doi: 10.1056/NEJM198810133191503. [DOI] [PubMed] [Google Scholar]
  21. Hillier S. L., Nugent R. P., Eschenbach D. A., Krohn M. A., Gibbs R. S., Martin D. H., Cotch M. F., Edelman R., Pastorek J. G., 2nd, Rao A. V. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995 Dec 28;333(26):1737–1742. doi: 10.1056/NEJM199512283332604. [DOI] [PubMed] [Google Scholar]
  22. Hook E. B. Human teratogenic and mutagenic markers in monitoring about point sources of pollution. Environ Res. 1981 Jun;25(1):178–203. doi: 10.1016/0013-9351(81)90089-x. [DOI] [PubMed] [Google Scholar]
  23. Ivanov I. Vliianie na preparata trikhomonatsid vurkhu bremennostta pri opitni zhivotni. Akush Ginekol (Sofiia) 1969;8(3):241–244. [PubMed] [Google Scholar]
  24. KOTCHER E., FRICK C. A., GIESEL L. O., Jr THE EFFECT OF METRONIDAZOLE ON VAGINAL MICROBIOLOGY AND MATERNAL AND NEONATAL HEMATOLOGY. Am J Obstet Gynecol. 1964 Jan 15;88:184–189. doi: 10.1016/0002-9378(64)90253-4. [DOI] [PubMed] [Google Scholar]
  25. Keith L. G., Friberg J., Fullan N., Bailey R., Berger G. S. The possible role of Trichomonas vaginalis as a "vector" for the spread of other pathogens. Int J Fertil. 1986 Sep-Oct;31(4):272–277. [PubMed] [Google Scholar]
  26. Kurki T., Sivonen A., Renkonen O. V., Savia E., Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol. 1992 Aug;80(2):173–177. [PubMed] [Google Scholar]
  27. LYON F. A., SINYKIN M. B., BARR M. M. Trichomonal vaginitis treated with metronidazole. Am J Obstet Gynecol. 1963 Apr 1;85:955–958. doi: 10.1016/s0002-9378(16)35600-9. [DOI] [PubMed] [Google Scholar]
  28. MONROE S. E. Trichomoniasis. Clinical trial of metronidazole (Flagyl). Calif Med. 1963 May;98:256–259. [PMC free article] [PubMed] [Google Scholar]
  29. Magnin P., Ambroise-Thomas P., Thoulon J. M., Laurent H. M. Traitement par le métronidazole (8 832 RP) de la vaginite à trichomonas de la femme enceinte. Absence d'effets tératogènes. Rev Fr Gynecol Obstet. 1966 Dec;61(12):861–867. [PubMed] [Google Scholar]
  30. Martius J., Krohn M. A., Hillier S. L., Stamm W. E., Holmes K. K., Eschenbach D. A. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol. 1988 Jan;71(1):89–95. [PubMed] [Google Scholar]
  31. Minkoff H., Grunebaum A. N., Schwarz R. H., Feldman J., Cummings M., Crombleholme W., Clark L., Pringle G., McCormack W. M. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 1984 Dec 15;150(8):965–972. doi: 10.1016/0002-9378(84)90392-2. [DOI] [PubMed] [Google Scholar]
  32. Minkoff H. Prematurity: infection as an etiologic factor. Obstet Gynecol. 1983 Aug;62(2):137–144. [PubMed] [Google Scholar]
  33. Morales W. J., Schorr S., Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol. 1994 Aug;171(2):345–349. doi: 10.1016/s0002-9378(94)70033-8. [DOI] [PubMed] [Google Scholar]
  34. Morgan I. Metronidazole treatment in pregnancy. Int J Gynaecol Obstet. 1978;15(6):501–502. doi: 10.1002/j.1879-3479.1977.tb00742.x. [DOI] [PubMed] [Google Scholar]
  35. PARKER R. T., THOMAS W. L., JONES C. P. METRONIDAZOLE IN THE TREATMENT OF VAGINAL TRICHOMONIASIS: HEMATOLOGIC, NEUROLOGIC, AND LONG-TERM CLINICAL EVALUATIONS. South Med J. 1965 Feb;58:211–214. doi: 10.1097/00007611-196502000-00014. [DOI] [PubMed] [Google Scholar]
  36. PEREYRA A. J., LANSING J. D. UROGENITAL TRICHOMONIASIS; TREATMENT WITH METRONIDAZOLE IN 2002 INCARCERATED WOMEN. Obstet Gynecol. 1964 Oct;24:499–508. [PubMed] [Google Scholar]
  37. PERL G. METRONIDAZOLE TREATMENT OF TRICHOMONIASIS IN PREGNANCY. Obstet Gynecol. 1965 Feb;25:273–276. [PubMed] [Google Scholar]
  38. PERL G., RAGAZZONI H. Flagyl in treatment of "Trichomonas vaginalis" vaginitis. Obstet Gynecol. 1962 May;19:595–598. [PubMed] [Google Scholar]
  39. Pagnozzi A., Pavetto P. F., Malanetto C. Terapia trichomonicida in gravidanza. Considerazioni sull'impiego del metronidazolo. Minerva Ginecol. 1969 Jul 15;21(13):857–860. [PubMed] [Google Scholar]
  40. Piper J. M., Mitchel E. F., Ray W. A. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol. 1993 Sep;82(3):348–352. [PubMed] [Google Scholar]
  41. ROBINSON S. C., JOHNSTON D. W. Observations on vaginal trichomoniasis. II. Treatment with metronidazone. Can Med Assoc J. 1961 Nov 11;85:1094–1096. [PMC free article] [PubMed] [Google Scholar]
  42. Robinson S. C., Mirchandani G. Trichomonas vaginalis. V. Further observations on metronidazole (Flagyl) (including infant follow-up). Am J Obstet Gynecol. 1965 Oct 15;93(4):502–505. [PubMed] [Google Scholar]
  43. Rodin P., Hass G. Metronidazole and pregnancy. Br J Vener Dis. 1966 Sep;42(3):210–212. doi: 10.1136/sti.42.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rosa F. W., Baum C., Shaw M. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol. 1987 May;69(5):751–755. [PubMed] [Google Scholar]
  45. Rosene K., Eschenbach D. A., Tompkins L. S., Kenny G. E., Watkins H. Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis. 1986 Jun;153(6):1028–1037. doi: 10.1093/infdis/153.6.1028. [DOI] [PubMed] [Google Scholar]
  46. Ross S. M., van Middelkoop A. Trichomonas infection in pregnancy--does it affect perinatal outcome? S Afr Med J. 1983 Apr 9;63(15):566–567. [PubMed] [Google Scholar]
  47. Rustia M., Shubik P. Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC(WI)BR rats. J Natl Cancer Inst. 1979 Sep;63(3):863–868. doi: 10.1093/jnci/63.3.863. [DOI] [PubMed] [Google Scholar]
  48. Rustia M., Shubik P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst. 1972 Mar;48(3):721–729. [PubMed] [Google Scholar]
  49. SCHRAM M., KLEINMAN H. Use of metronidazole in the treatment of trichomoniasis. Am J Obstet Gynecol. 1962 May 15;83:1284–1287. doi: 10.1016/s0002-9378(16)36036-7. [DOI] [PubMed] [Google Scholar]
  50. SCOTT-GRAY M. METRONIDAZOLE IN OBSTETRIC PRACTICE. J Obstet Gynaecol Br Commonw. 1964 Feb;71:82–85. doi: 10.1111/j.1471-0528.1964.tb04246.x. [DOI] [PubMed] [Google Scholar]
  51. Taylor R. W. Pregnancy after pelvic floor repair. Am J Obstet Gynecol. 1966 Jan 1;94(1):35–39. doi: 10.1016/0002-9378(66)90377-2. [DOI] [PubMed] [Google Scholar]
  52. WATT L., JENNISON R. F. Metronidazole treatment of trichomoniasis in the female. Report of an extended trial. Br Med J. 1962 Feb 3;1(5274):276–279. doi: 10.1136/bmj.1.5274.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. WHITELAW M. J., FOX L. P., SCHLICHTING F. R. RESULTS OF TREATMENT OF TRICHOMONIASIS WITH METRONIDAZOLE (FLAGYL) IN PRIVATE AND CLINIC PATIENTS. West J Surg Obstet Gynecol. 1963 Sep-Oct;71:232–233. [PubMed] [Google Scholar]
  54. WILLIAMS B. F. Metronidazole in the treatment of trichomonal infections. A clinical study. Obstet Gynecol. 1962 Nov;20:611–614. [PubMed] [Google Scholar]
  55. Watts D. H., Krohn M. A., Hillier S. L., Eschenbach D. A. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol. 1990 Jan;75(1):52–58. [PubMed] [Google Scholar]
  56. ZACHARIAS L. F., SALZER R. B., GUNN J. C., DIERKSHEIDE E. B. Trichomoniasis and metronidazole. Am J Obstet Gynecol. 1963 Jul 15;86:748–752. doi: 10.1016/s0002-9378(16)35190-0. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES